Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 10 2020
Historique:
received: 18 05 2020
accepted: 05 10 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 15 1 2021
Statut: epublish

Résumé

Prevalence of sarcopenia is high in patients with chronic kidney disease (CKD), especially in those with dialysis. Various pathological conditions related to CKD, such as chronic inflammation, insulin resistance, and endothelial dysfunction, are thought to be associated with the development and progression of sarcopenia. Advanced glycation end products (AGE), one of the representative uremic toxins, have been shown to contribute to various CKD-associated complications. This study investigated the role of AGE in frailty and sarcopenia in patients and animals with CKD, respectively. In patients undergoing dialysis, serum AGE levels were significantly increased according to the frailty status and inversely associated with physical performance and activity. AGE accumulated in the gastrocnemius muscle of 5/6 nephrectomy mice in association with morphological abnormalities, capillary rarefaction, and mitochondrial dysfunction, all of which were completely inhibited by DNA-aptamer raised against AGE. Our present findings may suggest the pathological role of AGE in sarcopenia and frailty in CKD.

Identifiants

pubmed: 33077879
doi: 10.1038/s41598-020-74673-x
pii: 10.1038/s41598-020-74673-x
pmc: PMC7573579
doi:

Substances chimiques

Glycation End Products, Advanced 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17647

Références

Diabetes. 2013 Sep;62(9):3241-50
pubmed: 23630304
Nephrol Dial Transplant. 1998 Mar;13(3):685-99
pubmed: 9550648
Nephrology (Carlton). 2010 Jun;15(4):454-63
pubmed: 20609098
Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F1128-F1140
pubmed: 28381463
Age Ageing. 2019 Sep 1;48(5):696-702
pubmed: 31211360
J Am Soc Nephrol. 2007 Nov;18(11):2960-7
pubmed: 17942958
Diabetes. 2017 Jun;66(6):1683-1695
pubmed: 28385802
Med Hypotheses. 2007;69(3):666-8
pubmed: 17331665
J Am Soc Nephrol. 2016 Feb;27(2):354-70
pubmed: 26311460
Diabetologia. 2001 Feb;44(2):129-46
pubmed: 11270668
J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):132-7
pubmed: 19182228
Geriatr Gerontol Int. 2020 Jan;20(1):78-84
pubmed: 31758637
Med Sci Sports Exerc. 2012 Dec;44(12):2322-30
pubmed: 22776875
PLoS One. 2017 Apr 27;12(4):e0176230
pubmed: 28448584
Clin Interv Aging. 2014 Oct 06;9:1677-85
pubmed: 25336932
J Pathol. 2016 Feb;238(3):470-82
pubmed: 26586640
J Diabetes Investig. 2019 Sep;10(5):1332-1340
pubmed: 30677242
Eur J Clin Nutr. 2013 Mar;67(3):239-48
pubmed: 23361161
Am J Kidney Dis. 2013 Aug;62(2):339-51
pubmed: 23357108
Rejuvenation Res. 2008 Dec;11(6):1041-8
pubmed: 19086911
Circulation. 2006 Aug 8;114(6):597-605
pubmed: 16894049
Diab Vasc Dis Res. 2013 Sep;10(5):436-41
pubmed: 23766377
Age Ageing. 1997 Jul;26(4):315-8
pubmed: 9271296
Kidney Int. 2014 Mar;85(3):570-8
pubmed: 24107853
Diabetes Metab Syndr Obes. 2019 Jul 08;12:1057-1072
pubmed: 31372016
Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):748-55
pubmed: 21470837
BMJ Open. 2015 Sep 02;5(9):e008462
pubmed: 26338685
Ren Fail. 2016;38(3):364-71
pubmed: 26738817
Diabetes Care. 2017 Sep;40(9):1256-1263
pubmed: 28687542
J Oncol. 2019 Sep 4;2019:7387601
pubmed: 31565056
J Am Soc Nephrol. 2003 Jun;14(6):1614-22
pubmed: 12761263
Arch Intern Med. 2002 Nov 11;162(20):2333-41
pubmed: 12418947
Nephrol Dial Transplant. 2014 Sep;29(9):1655-65
pubmed: 23625972
Kidney Int. 2007 Nov;72(9):1113-21
pubmed: 17728703
Ren Fail. 2011;33(2):131-7
pubmed: 21332333
Kidney Int. 2004 Dec;66(6):2137-47
pubmed: 15569303
Kidney Int. 2014 Jun;85(6):1330-9
pubmed: 24284514
Geriatr Gerontol Int. 2017 Oct;17(10):1527-1533
pubmed: 27670391
Clin J Am Soc Nephrol. 2008 May;3(3):691-8
pubmed: 18256374
Curr Opin Nephrol Hypertens. 2018 Mar;27(2):113-120
pubmed: 29266014
Scand J Rheumatol. 2005 Nov-Dec;34(6):460-3
pubmed: 16393769
Am J Clin Nutr. 2008 Jan;87(1):106-13
pubmed: 18175743
Int J Clin Exp Med. 2013 Aug 01;6(7):532-9
pubmed: 23936591
J Gerontol A Biol Sci Med Sci. 2014 Jun;69(6):710-6
pubmed: 24127427
J Gerontol A Biol Sci Med Sci. 2007 Nov;62(11):1204-10
pubmed: 18000139
Am J Kidney Dis. 2000 Mar;35(3):365-80
pubmed: 10692262
Life Sci. 2009 Jun 5;84(23-24):853-6
pubmed: 19351540
Eur J Appl Physiol. 2010 Jan;108(1):191-5
pubmed: 19756703
J Bras Nefrol. 2015 Jan-Mar;37(1):98-105
pubmed: 25923756
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Ann N Y Acad Sci. 2005 Jun;1043:759-66
pubmed: 16037303
Age (Dordr). 2014;36(4):9665
pubmed: 24997017
Microcirculation. 2006 Jun;13(4):343-52
pubmed: 16611596
Nephrol Dial Transplant. 2009 Apr;24(4):1162-9
pubmed: 19015171
J Am Soc Nephrol. 2007 May;18(5):1525-33
pubmed: 17409314
Immunol Lett. 2015 Oct;167(2):141-6
pubmed: 26304702
J Am Soc Nephrol. 2014 Dec;25(12):2800-11
pubmed: 25012168
Acta Neuropathol. 1980;49(1):51-5
pubmed: 7355673
J Am Soc Nephrol. 2010 Mar;21(3):419-27
pubmed: 20056750
Nephrol Dial Transplant. 2000 Jul;15(7):953-60
pubmed: 10862630
Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E219-25
pubmed: 10662705
Glycoconj J. 2016 Aug;33(4):683-90
pubmed: 27338620
J Nutr. 2011 Sep;141(9):1726-30
pubmed: 21775524
J Appl Physiol (1985). 2007 Dec;103(6):2068-76
pubmed: 17901242
J Cardiovasc Pharmacol. 2015 Mar;65(3):289-95
pubmed: 25636076

Auteurs

Junko Yabuuchi (J)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Seiji Ueda (S)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. se-ueda@juntendo.ac.jp.

Sho-Ichi Yamagishi (SI)

Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Nao Nohara (N)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Hajime Nagasawa (H)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Keiichi Wakabayashi (K)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Takanori Matsui (T)

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.

Higashimoto Yuichiro (H)

Department of Chemistry, Kurume University School of Medicine, Kurume, Japan.

Tomoyasu Kadoguchi (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Tomoyuki Otsuka (T)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Tomohito Gohda (T)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Yusuke Suzuki (Y)

Department of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH